NCT00078000View on ClinicalTrials.gov

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

November 30, 2005

Conditions
Breast Neoplasms
Interventions
DRUG

SU011248

Trial Locations (10)

21231

Pfizer Investigational Site, Baltimore

46202

Pfizer Investigational Site, Indianapolis

80010

Pfizer Investigational Site, Aurora

90095

Pfizer Investigational Site, Los Angeles

94115

Pfizer Investigational Site, San Francisco

94904

Pfizer Investigational Site, Greenbrae

60612-3824

Pfizer Investigational Site, Chicago

02114

Pfizer Investigational Site, Boston

02115

Pfizer Investigational Site, Boston

02215

Pfizer Investigational Site, Boston

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY